MTA1 and prostate carcinoma: In agreement with our previous reported finding of MTA1 and E‐cadherin (E‐cad) inverse relationship in prostate cancer (Dhar et al., 2016, 2017), shMTA1 cells showed an expected increase in E‐cad levels compared to NS control cells (Fig. 4C–E).